Abeona Therapeutics Inc (ABEO) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Abeona Therapeutics Inc   (NASDAQ: ABEO)
 

Abeona Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Abeona Therapeutics Inc inventory turnover ratio, the Abeona Therapeutics Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.51 in the second quarter 2026, yet the ratio remained below the average, as ABEO's market remain challenging.Average inventory processing period, for the Abeona Therapeutics Inc in Jun 30 2026 quarter, has decreased to 242 days, compare to 410 days, in the Mar 31 2026 quarter.

Within Healthcare sector 259 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1477 in the first quarter 2026, to 1859.

ABEO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Abeona Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABEO Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 120.44 % - - - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 1.51 0.89 0.47 0.26 -
ABEO's Total Ranking # 1859 # 1477 # 0 # 0 # 0
Average inventory processing period 242 412 776 1409 -
Seq. Inventory Growth -2.2 % 10.21 % 13.26 % 80.57 % -
Seq. Cost of Sales Growth 54.93 % 158.24 % 113.93 % - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 70
Healthcare Sector # 260
Overall Market # 1859

Inventory Turnover Ratio Statistics
High Average Low
5.4 2.98 0.89
(Dec 31 2012)   (Mar 31 2026)



ABEO Company Profile >> Back to ABEO Efficiency Comparisons >> Compare ABEO Inventory Turnover Ratio to its Competitors

Financial Statements
Abeona Therapeutics Inc 's Inventories $ 6 Millions Visit ABEO's Balance sheet
Abeona Therapeutics Inc 's Cost of Revenues TTM $ 8 Millions Visit ABEO's Income Statement
What are ABEO's Sales? Visit ABEO's Sales by Segment

Other Inventory Turnover Ratios
Abeona Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ABEO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ABEO's Competitors
Inventory Turnover Ratio for ABEO's Suppliers
Inventory Turnover Ratio for ABEO's Customers

You may also want to know
ABEO's Sales Growth Rates ABEO's Pe Price to earnings ratio ABEO's Receivables Turnover Ratio ABEO's Stock Quote
ABEO's Net Income Growth Rates ABEO's Ps Price to Sales ratio ABEO's Sales per Employee ABEO's Asset Turnover Ratio
ABEO's Net Margin ABEO's Pb Price to Book ratio ABEO's Financial Strength Ratios ABEO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Biocryst Pharmaceuticals Inc   3.69 $ 20.926  Millions$ 6  Millions
Abbvie Inc   3.66 $ 18,365.000  Millions$ 5,016  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Tandem Diabetes Care Inc   3.46 $ 456.703  Millions$ 132  Millions
Baxter International Inc   3.46 $ 8,020.000  Millions$ 2,317  Millions
Mirum Pharmaceuticals Inc   3.40 $ 85.221  Millions$ 25  Millions
Zai Lab Limited  3.39 $ 195.542  Millions$ 58  Millions
Cadre Holdings inc   3.39 $ 399.991  Millions$ 118  Millions
Bausch Health Companies Inc   3.38 $ 3,783.000  Millions$ 1,120  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
Evolus Inc   3.37 $ 105.904  Millions$ 31  Millions
Gilead Sciences Inc   3.35 $ 6,217.000  Millions$ 1,857  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Exelixis Inc   3.28 $ 85.665  Millions$ 26  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Becton Dickinson And Company  3.25 $ 11,161.000  Millions$ 3,429  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Solventum Corporation  3.22 $ 3,421.000  Millions$ 1,061  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions

Date modified: 2026-09-03T11:26:55+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.